These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22419807)

  • 1. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
    Lu F; Tsai K; Chen HS; Wikramasinghe P; Davuluri RV; Showe L; Domsic J; Marmorstein R; Lieberman PM
    J Virol; 2012 May; 86(10):5752-62. PubMed ID: 22419807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
    Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
    J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
    Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
    J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
    Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
    J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
    Sun R; Liang D; Gao Y; Lan K
    J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
    Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
    J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
    Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
    J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.
    Vázquez Ede L; Carey VJ; Kaye KM
    J Virol; 2013 Nov; 87(22):12270-83. PubMed ID: 24006437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
    Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
    J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
    Hu J; Garber AC; Renne R
    J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex.
    Hu J; Yang Y; Turner PC; Jain V; McIntyre LM; Renne R
    PLoS Pathog; 2014 Jul; 10(7):e1004240. PubMed ID: 25033463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
    Cotter MA; Robertson ES
    Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter.
    Cloutier N; Flamand L
    J Biol Chem; 2010 Mar; 285(10):7208-21. PubMed ID: 20048166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
    Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.
    Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R
    J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
    Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
    PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.